Merck KGaA (OTCMKTS:MKGAF - Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 594,300 shares, a decrease of 15.1% from the March 31st total of 700,000 shares. Currently, 0.5% of the company's stock are sold short. Based on an average daily trading volume, of 900 shares, the days-to-cover ratio is presently 660.3 days.
Merck KGaA Stock Performance
Merck KGaA stock traded up $3.00 during mid-day trading on Monday, reaching $143.50. The company's stock had a trading volume of 257 shares, compared to its average volume of 762. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a twelve month low of $118.05 and a twelve month high of $200.56. The business has a 50 day moving average price of $138.39 and a 200-day moving average price of $146.24. The firm has a market cap of $18.55 billion, a price-to-earnings ratio of 21.91 and a beta of 0.96.
About Merck KGaA
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
